---
title: "Nine pharmaceutical companies signed price agreements with Trump to avoid tariffs. These include Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, Sanofi, AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced agreements with Trump"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270345197.md"
description: "Nine pharmaceutical companies signed price agreements with Trump to avoid tariffs, including Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, and Sanofi. AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced agreements"
datetime: "2025-12-19T19:25:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270345197.md)
  - [en](https://longbridge.com/en/news/270345197.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270345197.md)
generator: "portal-rs"
---

# Nine pharmaceutical companies signed price agreements with Trump to avoid tariffs. These include Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, Sanofi, AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced agreements with Trump

Nine pharmaceutical companies signed a price agreement with Trump to avoid tariffs. These include Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, Sanofi, AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced an agreement with Trump.

Risk Warning and Disclaimer

The market has risks, and investment should be cautious. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)

## Related News & Research

- [What's Going On With Amgen Stock Tuesday?](https://longbridge.com/en/news/298350093.md)
- [Bristol-Myers Squibb (BMY) Following Camzyos Data And Zola Cel Pause Still Looks Fully Valued](https://longbridge.com/en/news/298117403.md)
- [Will Long‑Term Camzyos Data and Real‑World Evidence Change Bristol Myers Squibb's (BMY) Narrative?](https://longbridge.com/en/news/298073103.md)
- [Nilsine Partners LLC Makes New Investment in Amgen Inc. $AMGN](https://longbridge.com/en/news/298130227.md)
- [Bristol Myers Swoons on Test Results](https://longbridge.com/en/news/298335284.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**